Company Announcements ES Cell and GE Healthcare agreed in December 2014 to cross license their respective stem cell patents for the development of cellular assays and models derived from stem cells for use in drug discovery and toxicity screening. SI BIO signed a distribution agreement in January with 2BScientific for the UK and Ireland. Indi […]
Company Announcements Horizon Discovery named Dr. David Smoller, chief business officer, to its Board in November 2014. TriLink BioTechnologies appointed inVentis Technologies as a distributor for India. BioPointe Scientific named Cambio as its UK distributor. Cellular Dynamic appointed Susan A. Willetts to its Board in November 2014. She is an advisory director of Goldman, Sachs […]
Comprising about 7% of the analytical- and life science–instrumentation market, the lab-automation segment covers five categories: liquid handling, microplate readers, management informatics, multiplex and high-throughput (HT) ELISA, and robotics. A medium-sized market, lab-automation techniques increase lab productivity by managing workflow, and increasing the speed, efficiency and accuracy of lab work. The overall lab-automation market grew […]
The life science (LS) market consists of 14 distinct technology categories and is the largest of all analytical-instrument markets, including aftermarket and service revenues. In this year’s forecast issue, the LS category also includes capillary electrophoresis, which was previously counted as part of the separations market. In 2014, the LS market increased 5.9% to $11.8 […]
BioInformatics LLC has announced the 2014 Life Science Industry Awards. BioInformatics is a research and advisory firm for the life science industry. BioInformatics acquired SDi in September. The Life Science Industry Awards were nominated and voted on by nearly 6,000 scientists through electronic surveys conducted in September and October. The Awards covered more than 25 […]
Company Announcements Abcam established direct service in Australia and New Zealand in August. In September, Abcam announced that Peter Keen will not seek reelection to its Board. Abcam entered into an exclusive license, supply and distribution agreement with Australia’s Children’s Cancer Institute for multidrug-resistance protein 4 inhibitors, Ceefourin 1 and Ceefourin 2. Nirmidas Biotech raised […]
Thirteen of the 16 companies in the IBO Laboratory Sales Index reported quarterly earnings before this issue’s publication. Including estimates for companies yet to report, third quarter revenue for the Index grew more than 5% excluding currency, to $6,304 million. Excluding Illumina, Index sales advanced approximately 3% organically. Operating profit improved more than 10% to […]
In September, Avacta Life Sciences began shipping Affimers from its online catalog, following shipment of its custom line over the summer. Affimers are small proteins engineered as alternatives to antibodies. Priced comparably to antibodies, 40 are currently available through Avacta’s website. Alastair Smith, PhD, chief executive of Avacta, told IBO, “Affimers are not restricted in […]
Company Announcements Avacta appointed Cosmo Bio as a Japanese distributor of custom Affimer services and catalog-reagent sales. In July, Phenomenex announced the spin-off of Neoteryx, which will provide Volumetric Absorptive Microsampling technology for the collection, handling and analysis of biological fluids. The first product, the Mitra Microsampling Device, collects 10 µL of fluid in seconds […]
Company Announcements For the fiscal first quarter ending June 30, Hitachi High-Technologies Science and Medical Systems (SMS) sales climbed 33% to ¥38.8 billion ($380.1 million = ¥102.09 = $1) to account for 25% of company revenues (see IBO 7/31/14). Medical product sales jumped 53%, and sales of Biotechnology and Other products grew 16% to account […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
